Apoptosis is the process in which external or internal cues induce self-elimination of the cell. Apoptosis is an evolutionarily conserved key process in the development of multicellular organisms and is also implicated in the aetiology of several diseases such as cancer and neurodegeneration.^[@bib1],\ [@bib2]^ In *Caenorhabditis elegans*, invariably, 131 somatic cells undergo apoptosis during development (developmental apoptosis) of the hermaphrodite,^[@bib3],\ [@bib4]^ and in the adult half of the germ cells are eliminated by apoptosis (physiological germ cell apoptosis).^[@bib5]^ These types of apoptosis in *C. elegans* depend on the core apoptotic machinery comprising the caspase CED-3,^[@bib6]^ the adaptor protein Apaf-1 homologue CED-4^[@bib7]^ and the anti-apoptotic Bcl-2 homologue CED-9.^[@bib8]^ Strong loss-of-function mutations in *ced-3* or *ced-4* as well as a gain-of-function (gf) mutation in *ced-9* completely inhibit apoptosis.^[@bib5],\ [@bib9]^ DNA damage can also induce germ cell apoptosis (DNA damage-induced apoptosis) in the hermaphrodite germline.^[@bib10]^ In addition to the core apoptotic machinery, DNA damage-induced apoptosis also depends on the tumour-suppressor p53 homologue CEP-1^[@bib11],\ [@bib12]^ and the BH3-only proteins EGL-1 and CED-13.^[@bib13],\ [@bib14]^ All of these genes are functioning inside the dying cells to regulate the killing process. However, the genes *vab-1* (ephrin receptor) and *kri-1* (ankyrin-repeat protein orthologous to the human KRIT1/CCM1) have been shown to cell nonautonomously regulate physiological and ionising radiation (IR)-induced germ cell apoptosis, respectively.^[@bib15],\ [@bib16]^

Apoptotic cells are removed by engulfment, and in the germline engulfment is carried out by the surrounding sheath cells.^[@bib17]^ Two partially redundant pathways regulate engulfment.^[@bib18]^ One pathway consists of the transmembrane receptor *ced-1,* the adaptor protein *ced-6* (GULP) and *ced-7* (ABC1).^[@bib19],\ [@bib20],\ [@bib21],\ [@bib22]^ The other pathway comprises the adaptor protein *ced-2* (CrkII), the guanine nucleotide-exchange factors *ced-5* (DOCK180) and *ced-12* (ELMO) and *ced-10* (RAC1).^[@bib23],\ [@bib24],\ [@bib25],\ [@bib26]^ Mutations in several engulfment genes impair the removal of dead cells, which consequently persist longer.^[@bib18]^

Cytoplasmic dyneins are multisubunit motor protein complexes associated with microtubules. Large heavy chains comprise the bulk of the dynein complexes and confer motor activity, whereas the intermediate and light chains are accessory subunits that bind cargo.^[@bib27],\ [@bib28]^ The mammalian dynein light chain DYNLL1 is highly conserved with 95% homology to the *C. elegans* homologue DLC-1. DYNLL1 is implicated in dynein-regulating processes such as vesicular and protein transport, cell division, mitotic spindle formation and nuclear migration.^[@bib29],\ [@bib30]^ DYNLL1 binds to a variety of proteins besides dynein including the following: the pro-apoptotic protein BimL,^[@bib31]^ p53-binding protein 1^[@bib32],\ [@bib33]^ and the cell cycle regulators Cdk2 and Ciz1.^[@bib34]^ There is increasing evidence that DYNLL1 can act independent of its association with microtubules.^[@bib35],\ [@bib36]^ Several interaction partners of DYNLL1 regulate cell viability,^[@bib31],\ [@bib33],\ [@bib34]^ and DYNLL1 is overexpressed in breast tumours.^[@bib37]^ In accordance with a high evolutionary conservation, the *C. elegans* homologue DLC-1 affects germ cell proliferation, and inactivation of *dlc-1* by RNA interference (RNAi) in a tumour-promoting background results in hyperproliferating and polyploid germ cells.^[@bib38]^

We previously conducted a whole-genome RNAi screen with a view of identifying genes conferring resistance to the chemotherapeutic drug hydroxyurea (HU) (unpublished). The genes identified in the screen were analysed for germ cell apoptosis, and RNAi against dynein light chain 1 (*dlc-1)* caused a significant increase in the number of apoptotic germ cells. In this study, we describe a novel role of *dlc-1* in regulating IR-induced germ cell apoptosis by a cell-nonautonomous function via *kri-1*. We show that DLC-1 is functioning via *egl-1* and *ced-13* independently of *cep-1.*

Results
=======

Lack of *dlc-1* induces germ cells to undergo apoptosis
-------------------------------------------------------

To investigate the effect of *dlc-1* inactivation on germ cell apoptosis, we treated worms with RNAi against *dlc-1* and quantified apoptosis using differential interference contrast (DIC) microscopy and the CED-1::GFP (green-fluorescent protein) reporter. During the engulfment process, the transmembrane receptor CED-1 expressed in sheath cells clusters around apoptotic cells.^[@bib19]^ CED-1::GFP (*Plim-7::ced-1::gfp*, *bcIs39*) can therefore be used to quantify apoptotic germ cells undergoing engulfment. The *dlc-1(RNAi)* animals had significantly more GFP-positive cells than the controls ([Figures 1a and b](#fig1){ref-type="fig"}). A significant increase in the number of apoptotic cells following RNAi against *dlc-1* was also seen using DIC microscopy ([Figures 1a and b](#fig1){ref-type="fig"}). The RNAi treatment reduced the expression of *dlc-1* with 80--90% compared with controls ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}).

We reasoned that the increased number of apoptotic cells in the *dlc-1(RNAi)* animals could be because of excessive germ cells undergoing apoptosis or an engulfment defect preventing their removal. The CED-1::GFP marker can only be used if proper internalisation of the dead cells is taking place during the engulfment process; consequently, the CED-1::GFP marker does not detect apoptotic cells in the engulfment-defective mutants *ced-5* and *ced-6*.^[@bib39]^ We confirmed that persistent cell corpses observable with DIC in *ced-5(tm1950)* and *ced-6(tm1826)* mutants could not be seen with the CED-1::GFP marker ([Figure 1c](#fig1){ref-type="fig"}). Therefore, as the apoptotic cells in *dlc-1(RNAi)* animals could be observed equally well with DIC and CED-1::GFP, RNAi against *dlc-1* did not result in an engulfment defect. Thus, *dlc-1(RNAi)* animals do not phenocopy engulfment-defective mutants.

To investigate whether *dlc-1* is also involved in somatic apoptosis during development, we analysed L1 larvae for the presence of persistent cell corpses in the head with DIC microscopy. Wild-type N2 larvae have no visible cell corpses, whereas engulfment mutants, such as *ced-5(tm1950)* and *ced-6(tm1826)*, have many persistent cell corpses^[@bib18]^ (and [Figure 1d](#fig1){ref-type="fig"}). Inactivation of *dlc-1* in wild-type N2 worms did not result in persistent cell corpses, indicating that *dlc-1* does not affect engulfment during development. Increased apoptosis during development can be seen in engulfment-defective mutant backgrounds, as the extra dead cells are not as efficiently removed as in wild-type worms. However, RNAi against *dlc-1* had no effect on the number of corpses observed in *ced-5* or *ced-6* mutants ([Figure 1d](#fig1){ref-type="fig"}). This suggests that RNAi against *dlc-1* does not affect somatic cell death or engulfment but specifically increases germ cell apoptosis.

DLC-1 affects apoptosis independently of the dynein motor complex
-----------------------------------------------------------------

In addition to *dlc-1,* the *C. elegans* genome encodes five other light chains (*dlc-2--6*). We speculated whether the observed apoptotic phenotype was specific for the inactivation of *dlc-1* or whether it was a general phenotype for all the dynein light chains. Following their inactivation, none of the other five light chains resulted in an increased number of apoptotic germ cells ([Figure 1e](#fig1){ref-type="fig"}). Furthermore, we also investigated the effect on apoptosis after knockdown of the main dynein heavy chain, *dhc-1.* As RNAi against *dhc-1* causes developmental arrest, we treated N2 wild-type worms with RNAi against *dhc-1* from the L4 stage and scored apoptosis 48 h later using DIC, but no effect on germ cell apoptosis was observed ([Figure 1f](#fig1){ref-type="fig"}). This indicates that the increase in apoptotic cells is specific for *dlc-1* and is not a general phenotype from a disrupted dynein complex.

Lack of *dlc-1* induces apoptosis through CED-3, CED-9 and LIN-35
-----------------------------------------------------------------

Strong loss-of-function mutations in *ced-3* or *ced-4* completely inhibit both somatic and germ cell apoptosis. We inactivated *dlc-1* in a mutant harbouring the strong loss-of-function allele *ced-3(n717)* and expressing the CED-1::GFP marker. The *ced-3(n717)* mutation completely suppressed apoptosis because of RNAi against *dlc-1* ([Figure 2a](#fig2){ref-type="fig"}). *ced-3*-independent apoptosis has been reported following RNAi against the inhibitor of cell death-1 (*icd-1*) gene, which encodes the beta-subunit of the nascent polypeptide-associated complex (bNAC).^[@bib40]^ Therefore, as an additional control we treated *ced-3(n717)* mutants with *icd-1* RNAi. In agreement with the previous report, we observed that *ced-3* could not completely suppress apoptosis induced by RNAi against *icd-1* ([Supplementary Figure S2](#sup1){ref-type="supplementary-material"}). Thus, inactivation of *dlc-1* increases the number of apoptotic germ cells exclusively through the *ced-3* pathway. As almost all types of apoptosis in *C. elegans* require the core apoptotic machinery, we next decided to use an epistasis analysis approach to determine the subtype of apoptosis influenced by RNAi against *dlc-1.*

Physiological germ cell death is independent of the core apoptotic machinery gene *ced-9.*^[@bib5]^ We tested whether *dlc-1(RNAi)-*induced apoptosis was independent of a *ced-9* gf mutation *(n1950)*. However, *dlc-1(RNAi)*-induced apoptosis was completely abolished in the *ced-9(gf)* mutant, indicating that *ced-9* was required for *dlc-1(RNAi)* to induce apoptosis ([Figure 2b](#fig2){ref-type="fig"}). Thus, *dlc-1* is not involved in physiological germ cell death.

Inactivation of *dlc-1* results in a tumorous germline and unpaired chromosomes in the oocytes.^[@bib38]^ Therefore, we hypothesised that these phenotypes might lead to DNA damage-induced apoptosis through CED-9. In *C. elegans,* DNA damage-induced apoptosis is dependent on the p53 homologue *cep-1*.^[@bib11]^ Hence, we investigated whether *dlc-1(RNAi)* could induce apoptosis in *cep-1(gk138)* mutants. RNAi against *dlc-1* induced apoptosis in the *cep-1* mutants to the same extent as in wild-type N2 animals ([Figure 2c](#fig2){ref-type="fig"}). Thus, *dlc-1(RNAi)* does not result in apoptosis because of an increased level of DNA damage. Unpaired chromosomes can trigger a synapsis checkpoint independent of the DNA-damage checkpoint, which requires the activity of PCH-2, the *C. elegans* homologue of PCH2, a budding yeast pachytene checkpoint gene.^[@bib41]^ We found that inactivation of *dlc-1* induced apoptosis in *pch-2* mutants to a similar extent as seen in wild-type N2 animals ([Figure 2d](#fig2){ref-type="fig"}). Thus, *dlc-1(RNAi)* does not induce apoptosis because of unpaired chromosomes.

Several pathways have been shown to feed into the core apoptotic machinery through CED-9, such as the mitogen-activated protein kinase (MAPK) and retinoblastoma (RB) tumour-suppressor pathways.^[@bib5],\ [@bib42]^ Overactivation of MAPK -- for example, by loss of the inhibitor GLA-3 -- causes excessive germ cell apoptosis.^[@bib43]^ *gla-3* mutants and *dlc-1(RNAi)* animals had approximately equal levels of apoptosis, whereas the *gla-3(ok2684);dlc-1(RNAi)* animals had significantly higher levels of germ cell apoptosis than either of the single mutant/RNAi animals ([Figure 2e](#fig2){ref-type="fig"}), consistent with *gla-3* and *dlc-1* functioning in separate pathways to induce apoptosis. LIN-35, the *C. elegans* ortholog of the RB tumor-suppressor p105Rb, is involved in both physiological and DNA damage-induced germ cell apoptosis; however, contrary to *gla-3,* loss of *lin-35* inhibits apoptosis.^[@bib42]^ In *lin-35(n745)* mutants, RNAi against *dlc-1-*induced apoptosis was completely suppressed ([Figure 2f](#fig2){ref-type="fig"}). Thus, we conclude that normally DLC-1 acts upstream of LIN-35 to protect against apoptosis. LIN-35 represses the transcription of *ced-9*;^[@bib42]^ hence, we hypothesised that DLC-1 could directly or indirectly affect the activity of LIN-35 and thereby the transcription of *ced-9*. We analysed the expression of *lin-35* and *ced-9* in *dlc-1(RNAi)* animals but observed no changes in their expression ([Supplementary Figure S3](#sup1){ref-type="supplementary-material"}), demonstrating that *dlc-1* does not affect *lin-35* and *ced-9* activity at the transcriptional level.

DLC-1 is a part of the response to IR-induced apoptosis
-------------------------------------------------------

As *dlc-1(RNAi)*-induced apoptosis was independent of *cep-1* but dependent on *lin-35*, both of which are involved in response to DNA damage, we evaluated how *dlc-1(RNAi)* animals responded to DNA damage induced by IR. Interestingly, IR did not increase the number of apoptotic cells in *dlc-1(RNAi)* animals ([Figure 3a](#fig3){ref-type="fig"}), indicating that IR and *dlc-1* function in a common pathway.

In human cells, DLC-1 facilitates the transport of p53 to the nucleus in response to DNA damage.^[@bib32],\ [@bib33]^ The lack of response to IR in *dlc-1(RNAi)* animals could arise from the mislocalisation or malfunction of CEP-1. Using western blotting with an antibody against the C-terminal of CEP-1, no difference in CEP-1 localisation was observed between control and *dlc-1(RNAi)* animals; in both CEP-1 was accumulated exclusively in the nucleus ([Figure 3b](#fig3){ref-type="fig"}). Furthermore, to evaluate the activity of CEP-1 in *dlc-1(RNAi)* animals, we used quantitative real-time polymerase chain reaction (qRT-PCR) to measure the expression levels of the CEP-1 target genes *egl-1* and *ced-13*, which are upregulated after exposure to IR.^[@bib14]^ In both the control and *dlc-1(RNAi)* animals, the expression levels of *egl-1* and *ced-13* were upregulated after exposure to IR, suggesting that CEP-1 functions correctly in *dlc-1(RNAi)* animals ([Figure 3c](#fig3){ref-type="fig"}). In contrast, *cep-1* mutants could not induce *egl-1* transcription in response to IR ([Supplementary Figure S4](#sup1){ref-type="supplementary-material"}).

We then investigated whether DLC-1 acted in the DNA-damage response pathway downstream or in parallel to *cep-1*. We quantified germ cell corpses using DIC in *egl-1(n1084n3082);dlc-1(RNAi)*, *ced-13(tm536);dlc-1(RNAi)* and *egl-1(n1084n3082);ced-13(tm536);dlc-1(RNAi)* animals and found that *dlc-1* RNAi-induced apoptosis was strongly reduced in these mutant backgrounds compared with RNAi against *dlc-1* in a wild-type background ([Figure 3d](#fig3){ref-type="fig"}). Thus, both functional CED-13 and EGL-1 are required for RNAi against *dlc-1* to induce apoptosis. However, RNAi against *dlc-1* did not regulate the transcription of *egl-1* and *ced-13* in the absence of DNA damage ([Figure 3c](#fig3){ref-type="fig"}), suggesting that DLC-1 might regulate *egl-1* and *ced-13* at the protein level.

Other *cep-1*-independent apoptotic regulators have been described, including *sir-2.1,*^[@bib44]^ *pmk-1*^[@bib45],\ [@bib46]^ and *pmk-3*.^[@bib47]^ Therefore, we investigated the epistatic relationship between *dlc-1* and these three genes. SIR-2.1 is a member of the Sirtuins family of NAD^+^-dependent protein deacetylases shown to regulated IR-induced apoptosis. The p38 homologues of mitogen-activated protein kinase, *pmk-1* and *pmk-3,* are necessary for bacterial and copper-induced germ cell apoptosis, respectively. Neither *sir-2.1*, *pmk-1* nor *pmk-3* could suppress *dlc-1(RNAi)*-induced apoptosis, indicating that they act through different pathways ([Figure 3e](#fig3){ref-type="fig"}).

DLC-1 is functioning cell nonautonomously through *kri-1*
---------------------------------------------------------

To study the expression and localisation of DLC-1, we generated two independent transgenic lines (P~*dlc-1*~*::dlc-1::gfp*) expressing GFP-tagged DLC-1 under the regulation of the *dlc-1* promotor ([Figure 4](#fig4){ref-type="fig"}). We found DLC-1 to be expressed in numerous tissues including those of the intestine ([Figure 4a](#fig4){ref-type="fig"}), body wall muscles ([Figure 4b](#fig4){ref-type="fig"}), germ cells and oocytes ([Figure 4c](#fig4){ref-type="fig"}), the rectal valve cell ([Figure 4d](#fig4){ref-type="fig"}) and unidentified cells in the head ([Figure 4e](#fig4){ref-type="fig"}). DLC-1 was expressed at all developmental stages from the one-cell embryo. To validate that the transgenic strain was expressing wild-type DLC-1, we treated it with RNAi against *dlc-1* and observed that the GFP level was significantly reduced ([Supplementary Figure S5](#sup1){ref-type="supplementary-material"}), and we used western blotting to confirm that the full-length fusion protein was being expressed (data not shown).

As DLC-1 was expressed both in the germ cells and in somatic tissues, we investigated in which of these tissues inactivation of *dlc-1* resulted in increased germ cell apoptosis. The *ppw-1* gene encodes a member of the argonaute family of proteins and is required for efficient RNAi in germ cells.^[@bib48]^ The *rrf-1* gene encodes an RNA-directed RNA polymerase required for activation of the RNAi pathway in somatic cells.^[@bib49]^ We treated two different alleles of *rrf-1 (pk1417* and *ok589)* and *ppw-1 (pk2505* and *pk1425)* with RNAi against *dlc-1* and quantified the number of apoptotic cells using DIC. We observed that the increase in apoptotic cells caused by *dlc-1* RNAi was completely abolished in the *rrf-1* mutants but not affected in the *ppw-1* mutants ([Figure 5a](#fig5){ref-type="fig"}). Therefore, inactivation of *dlc-1* only in somatic cells gives rise to the increase in apoptotic cells. To verify the specificity of the *rrf-1* and *ppw-1* mutants, we treated them with *ced-1* RNAi, which induces an engulfment defect. CED-1 functions in the somatic sheath cells but not in the germ cells. As expected, *ced-1(RNAi)* only induced an engulfment defect in *ppw-1* mutants but not in *rrf-1* mutants ([Supplementary Figure S6](#sup1){ref-type="supplementary-material"}).

As *dlc-1* functions in the response to IR, we investigated whether IR regulates *dlc-1* at the transcriptional or translational level. However, using qPCR no changes in *dlc-1* transcription in response to IR was observed (data not shown). Likewise, we did not observe any changes in the levels of DLC-1::GFP after IR in whole animals ([Figure 4f](#fig4){ref-type="fig"}). We also examined the localisation of DLC-1::GFP after IR, but changes were observed neither in whole animals ([Figure 4g](#fig4){ref-type="fig"}) nor in sheath cells ([Supplementary Figure S7](#sup1){ref-type="supplementary-material"}). We also hypothesised that overexpression of DLC-1 might protect against IR-induced apoptosis. However, we observed no difference in the number of apoptotic cells between wild-type N2 and DLC-1::GFP animals when treated with 120 or 60 Gy ([Figure 5b](#fig5){ref-type="fig"} and [Supplementary Figure S8](#sup1){ref-type="supplementary-material"}).

The clear involvement of DLC-1 in somatic tissues in regulating germ cell apoptosis led us to investigate a possible involvement of *kri-1*. The KRI-1 ankyrin-repeat protein is orthologous to the human KRIT1/CCM1, and it is required for IR-induced apoptosis in a novel pathway acting in somatic cells.^[@bib16]^ We examined the epistatic relationship between *dlc-1* and *kri-1* by treating *kri-1(ok1251)* mutants with RNAi against *dlc-1*. *kri-1* mutants fed *dlc-1* RNAi had significantly fewer apoptotic germ cells than wild-type N2 animals treated with RNAi against *dlc-1* ([Figure 5c](#fig5){ref-type="fig"}). This indicates that *kri-1* is necessary for *dlc-1(RNAi)*-induced apoptosis. Next, we used a strain expressing the functional KRI-1::GFP protein to examine whether *dlc-1* could regulate the expression or localisation of KRI-1. We treated KRI-1::GFP animals with *dlc-1* RNAi for 3 days and scored the expression of GFP compared with animals grown on control RNAi. Our results show that *dlc-1* RNAi increases the expression of KRI-1::GFP on average with 57% ([Figure 5d](#fig5){ref-type="fig"}), demonstrating that *dlc-1* can regulate KRI-1. We did not observe any change in localisation of KRI-1::GFP because of RNAi against *dlc-1* ([Supplementary Figure S9](#sup1){ref-type="supplementary-material"}). To test the possibility that DLC-1 and KRI-1 might interact directly, we expressed *C. elegans* DLC-1 and KRI-1 in a mammalian two-hybrid system using luciferase as readout. As DLC-1 is known to bind to itself in mammalian cells, we used this interaction as a positive control ([Figure 5e](#fig5){ref-type="fig"}). However, we did not observe any interaction between DLC-1 and KRI-1 ([Figure 5f](#fig5){ref-type="fig"}). Based upon our results we propose that DLC-1 is regulating KRI-1 in response to IR-induced apoptosis to mediate a pro-apoptotic signal from somatic cells to germ cells ([Figure 6](#fig6){ref-type="fig"}).

Discussion
==========

We have identified DLC-1 as a new gene required for proper apoptotic signalling between somatic cells and germ cells in response to IR acting through KRI-1. Our study is thus adding to the knowledge of the recently described KRI-1-mediated response to IR. Firstly, we find that KRI-1 is required for CED-3-dependent apoptosis induced by RNAi against *dlc-1*. Secondly, our data show that DLC-1 regulates the level of KRI-1. Thirdly, we show that the DLC-1/KRI-1 signalling pathway operates via EGL-1 and CED-13. Based upon these results we propose a model in which DLC-1 is part of the response to IR-induced apoptosis through a cell-nonautonomous pathway depending on *kri-1* and independent of *cep-1* ([Figure 6](#fig6){ref-type="fig"}). Consistent with this model we found that IR did not induce additional apoptosis in *dlc-1(RNAi)* animals. Our results strongly support that intercellular communication between somatic cells and germ cells is required for proper regulation of the cell-killing process.

Our model raised the possibility that *dlc-1* was directly regulated by IR at the transcriptional or translational level. However, we did not observe any changes in expression or localisation of DLC-1::GFP in response to IR. Instead, IR may induce post-translational modifications to DLC-1. In mammalian cells, DLC-1 can be phosphorylated on Ser88 that inactivates DLC-1 by disrupting the homodimer.^[@bib50]^ This phosphorylation can be carried out by the p21-activated kinase, Pak-1.^[@bib37]^

We have demonstrated that *dlc-1(RNAi)-*induced apoptosis is dependent on EGL-1 and CED-13; however, DLC-1 is not involved in transcriptional regulation of *egl-1* and *ced-13*. Rather our model predicts a second layer of regulation of the proteins involved in IR-induced apoptosis; CEP-1 regulates the transcription of *egl-1* and *ced-13,* whereas DLC-1 indirectly regulates their activity at the protein level through a cell-nonautonomous pathway, giving a tighter and more fine-tuned regulation of IR-induced apoptosis.

At the molecular level, several mechanisms may explain how DLC-1 regulates apoptosis. One possible underlying molecular mechanism could be that DLC-1 normally binds a pro-apoptotic signal/protein. *dlc-1* inactivation or exposure to IR then leads to the release of inhibition of such pro-apoptotic signal that is then transmitted to the germ cells to induce apoptosis by activating the EGL-1 and CED-13 proteins. A similar cell-autonomous mechanism has been described in mammalian cells where DLC-1 binds to the BH3-only protein BimL and sequesters it to the dynein complex. Upon apoptotic stimuli, the DYNLL1--BimL dimer is released and translocated to the mitochondria to induce apoptosis.^[@bib31]^ The cell-nonautonomous system that we are describing must contain an intermediate regulating protein, as DLC-1 and EGL-1/CED-13 are functioning in separate cells. This is not unlikely because mammalian BH3-only proteins have been shown to be regulated post-translationally.^[@bib51]^ Our data show that KRI-1 is one protein mediating the signalling from DLC-1 to EGl-1 and CED-13. We did not find experimental support for a direct interaction between DLC-1 and KRI-1; however, DLC-1 does regulate the level of KRI-1. Further studies will be required to determine how and where DLC-1 is regulating KRI-1, and which downstream targets are employed in transmitting the apoptotic signal from the somatic cells to the germ cells. Interestingly, it has previously been shown that KRI-1 is expressed in the intestine and pharynx and that it mediates a signal between the reproductive system and the intestine required for longevity because of reduced germline signalling.^[@bib52]^ As *dlc-1* is also expressed in these tissues, it is tempting to speculate that they might be the site of interaction between DLC-1 and KRI-1, although their interaction also could be purely genetic and cell-nonautonomous.

Our results may also explain why DLC-1 is overexpressed in human breast cancers.^[@bib37]^ It is possible that overexpression of DLC-1 could potentially protect cancer cells from undergoing apoptosis. Furthermore, our observation that DLC-1 mediates apoptotic signalling between somatic cells and germ cells validates the importance for cell-nonautonomous signalling. This intertissue communication also has vital roles in other *C. elegans* life history traits, such as lifespan^[@bib52]^ and proliferation and differentiation of the germline.^[@bib53]^ Decoding pathways for intertissue communication is also of crucial importance in higher organism such as humans to better understand the interplay and regulation of individual organs required to maintain an intact organism.

Materials and Methods
=====================

Strains and culture conditions
------------------------------

All strains were maintained at 20 °C on standard nematode growth medium (NGM) spotted with *Escherichia coli* strain OP50. The following strains were used: Wild-type N2, MD701 (*bcIs39*\[P(*lim-7)ced-1*::GFP +*lin-15*(+)\]), MT1522 *ced-3(n717), ced-6(tm1826),* MT4770 *ced-9(n1950),* FX536 *ced-13(tm536),* NL2098 *rrf-1(pk1417),* RB798 *rrf-1(ok589),* NL2550 *ppw-1(pk2505),* NL3511 *ppw-1(pk1425),* TJ1 *cep-1(gk138),* CA388 *pch-2(tm1458),* MT10430 *lin-35(n745),* RB2026 *gla-3(ok2684),* MT8735 *egl-1(n1084n3082), ced-5(tm1950), egl-1(n1084n3082);ced-13(tm536),* EG6699 (ttTi5605 II; *unc-119 (ed3)* III; oxEx1578), *pmk-3(ok169)*, *pmk-1(km25), sir-2.1(ok434)*, CF2052 *kri-1(ok1251), muEx353\[Pkri-1::kri-1::gfp; odr-1::rfp\],* OLS400 *aarSi1\[Pdlc-1::DLC-1::GFP cb-unc-119(+)\]* II and OLS401 *aarSi2\[Pdlc-1::DLC-1::GFP cb-unc-119(+)\]* II.

Double mutants were made by crossing MD701 males with hermaphrodites of the desired phenotype. For *cep-1;ced-1*::GFP, *pch-2;ced-1*::GFP and *gla-3;ced-1*::GFP, the homozygous F2s were selected by using standard PCR (see [Supplementary Table S1](#sup1){ref-type="supplementary-material"} for primers) and GFP expression. *ced-3;ced-1::*GFP was made by using the marker *unc-26(e1196)*. The marker was first crossed to MD701, and F2s were selected by their Unc phenotype and GFP expression. This strain was then crossed to *ced-3,* and F2s were selected for GFP expression and non-Unc phenotypes. To validate the *cep-1* mutant, we used IR to introduce DNA damage-induced apoptosis. As expected, the *cep-1* mutant had no apoptotic cells in the germline after IR ([Supplementary Figure S10](#sup1){ref-type="supplementary-material"}).

Generation of transgenic strains by MosSCI
------------------------------------------

The plasmid containing P~*dlc-1*~*::dlc-1::gfp* was generated by using standard Gateway techniques (Invitrogen, Naerum, Denmark). pENTRY clones for the *dlc-1* promoter and open reading frame (ORF) were generated by using PCR products amplified with Gateway and gene-specific primers ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}). The vector pJA256 (Addgene, Cambridge, MA, USA) was used as pENTRY clone for GFP. The Gateway destination vector was pCFJ150 (Addgene) containing an *unc-119* rescue fragment.

MosSCI was performed as described^[@bib54]^ using direct insertion based on injection of *unc-119* animals (EG6699 strain) with an injection mix comprised of the plasmids (all from Addgene): pCFJ150 containing P~*dlc-1*~*::dlc-1::gfp* (final conc. 15 ng/*μ*l), pCFJ601 (final conc. 50 ng/*μ*l), pMA122 (final conc. 10 ng/*μ*l), pGH8 (final conc. 10 ng/*μ*l), pCFJ90 (final conc. 2.5 ng/*μ*l) and pCFJ104 (final conc. 5 ng/*μ*l). Selection was based on *peel-1* toxin, wild-type movement, absence of mCherry markers and presence of GFP.

Two independent lines OLS400 and OLS401 were created, and expression of full-length DLC-1 was confirmed by using western blotting with an antibody against GFP. The lines were subsequently back-crossed to wild-type N2 four times to eliminate background mutations.

RNAi
----

The RNAi clone against *dlc-1*(T26A5.9) was from the OpenBiosystems RNAi Library (Thermo Fisher Scientific, Waltham, MA, USA). RNAi clones against *dlc-2, dlc-3, dlc-4, dlc-5* and *dlc-6* were generated by standard cloning techniques and inserted into pL4440 and expressed by HT115 cells. All RNAi clones were verified by sequencing (See [Supplementary Table S1](#sup1){ref-type="supplementary-material"} for primers). RNAi was performed by feeding on NGM plates containing 1 mM isopropyl thiogalactoside and ampicillin (100 *μ*g/ml).^[@bib55]^ Worms feed HT115 bacteria containing an empty pL4440 vector (ctrl RNAi) were used as controls.

In all germline apoptosis assays following RNAi against *dlc-1,* apoptosis was scored in the first generation on RNAi. For assays with RNAi against *dlc-2--6,* apoptosis was scored both in first and second generation on RNAi to eliminate maternal rescue. For *dhc-1* RNAi, animals were treated with RNAi from L4 and apoptosis was scored 48 h later.

For developmental apoptosis in the head of L1 larvae on *dlc-*1 RNAi, eggs were picked onto *dlc-1* RNAi plates and their progeny was scored for apoptosis.

Quantification of apoptosis
---------------------------

Cells undergoing apoptosis were distinguished from normal cells as refractile, button-like discs by using DIC microscopy (Zeiss Axiophot Microscope equipped with a Micropublisher 3.3 RTV Qimaging camera) as described.^[@bib56]^ Alternatively, the CED-1::GFP (P~*lim-7*~*ced-1::*GFP, *bcIs39*) reporter was used to score apoptotic cells using fluorescence microscopy (Leica DNI300B microscope equipped with an Olympus DP72 camera) as previously described.^[@bib19]^ Briefly, worms were synchronized as eggs and apoptosis was scored after 72 and 96 h using P~*lim-7*~*ced-1*::GFP and/or DIC. Worms for DIC were grown at 20 °C, whereas P~*lim-7*~*ced-1*::GFP worms were grown at 25 °C to obtain stronger expression of GFP. Worms were anesthetised in 5 mM levamisole in S-basal (0.1 M NaCl, 0.05 M H~2~PO~4~ (pH 6)) and mounted on 2% agarose pads. For DNA damage-induced apoptosis, hermaphrodites were synchronised as L4 and exposed to 60, 90 or 120 Gy using a ^137^Cs source (dose rate: 2 Gy/min). Germ cell apoptosis was scored 24-h post treatment. For quantification of developmental apoptosis, freshly hatched L1 larva was anaesthetised in 100 mM levamisole in S-basal and mounted on 2% agarose pads.

**Quantification of KRI-1::GFP expression** Pictures of individual worms were taken with equal exposure time for ctrl and *dlc-1(RNAi)* worms. Pictures were converted to grey-scale and analysed by *mean grey value* in ImageJ (Rasband, W. S., Image J, US NIH, Bethesda, MD, USA). Twenty worms were analysed for each experiment and condition.

Nuclear and cytoplasmic extracts and detection of CEP-1
-------------------------------------------------------

Extracts with minor modifications were prepared as described.^[@bib57]^ Approximately 10 000 *rrf-3* worms were grown from eggs to adulthood on *dlc-1* or empty vector RNAi plates. Worms were washed three times in S-basal. Three microlitre Extraction Buffer (10 mM Hepes, pH 7.1, 5 mM MgCl~2~, 10% glycerol, 2 mM dithiothreitol (DTT), Complete Protease inhibitor Cocktail Tablets (Roche Applied Science, Hvidover, Denmark)) was added before the worms were pelleted by centrifugation. The pellet was resuspended in 0.5 volumes of Extraction Buffer and snap-frozen in liquid nitrogen. The frozen worms were grinded in liquid nitrogen in a pre-chilled mortar and dissolved in 3 ml Extraction Buffer and homogenised (10 strokes) in a Wheaton stainless steel tissue grinder (24--7). Samples were spun 10 min, 18 000 *g* in 50 ml tubes. The supernatant (cytoplasmic fraction) was frozen in liquid nitrogen. The pellet was washed twice in 500 *μ*l Extraction buffer and then dissolved in 300 *μ*l Nuclear Extraction Buffer (Extraction Buffer with 500 mM NaCl) and incubated for 30 min, at 4 °C on a roller table. After centrifugation for 10 min, at 18 000 *g* in 50 ml tubes at 4 °C, the supernatant (nuclear fraction) was frozen in liquid nitrogen. Bio-Rad (Copenhagen, Denmark) sample buffer and reducing agent were added to 15 *μ*l of the samples, boiled for 5 min before being fractionated on Bio-Rad CriterionXT precast gels (12%) and electroblotted onto a nitrocellulose membrane using a Bio-Rad Trans-blot cell and subsequently incubated with 2% skim milk in 1 × phosphate-buffered saline (PBS). Membranes were probed with primary antibody followed by horseradish peroxidase (HRP)-conjugated secondary antibody. HRP was visualised using Amersham ECL plus detection systems (GE Healthcare, Brøndby, Denmark). Presence of CEP-1 in the extracts was detected with western blotting (standard protocol) using a rabbit anti-cep-1 (cN-18) antibody (Santa Cruz Biotechnology, Dallas, TX, USA) and HRP-conjugated swine anti-rabbit antibody (DakoCytomation, Glostrup, Denmark) as secondary antibody. An anti-actin antibody (JLA20, Calbiochem, Merck Chemicals, Hellerup, Denmark) was used as control for equal loading.

Ionising radiation
------------------

Hermaphrodites were synchronized at the L4 stage and irradiated with 90 Gy using a ^137^Cs source (dose rate: 2 Gy/min). After radiation, the worms were transferred to fresh plates. Twenty-four hours post radiation, worms were washed in S-basal and then snap-frozen in liquid nitrogen and kept at −80 °C.

Quantitative real-time PCR
--------------------------

For RNA isolation, Trizol (Invitrogen) and chloroform extraction were performed using Phase Lock Gel Heavy 2 ml spin columns (5prime, VWR) followed by isopropanol precipitation. The quality of the RNA was assessed using gel electrophoresis and the concentration was measured using a NanoDrop 1000 (Thermo Scientific, Waltham, MA, USA). One microgram of total RNA was reverse-transcribed into complementary DNA (cDNA) using iScript cDNA Synthesis Kit (Bio-rad) following the manufacturer\'s protocol. Gene-specific qRT-PCR using cDNA, appropriate primers and Power SYBRGreen PCR Master Mix (Applied Biosystems, Naerum, Denmark), was performed on a Stratagene MX3000P machine (La Jolla, CA, USA). All samples were run in technical triplicates. Water was used as negative control. All primers were designed to span exon--exon boundaries (See [Supplementary Table S1](#sup1){ref-type="supplementary-material"} for primers). Test gene *C*~T~ values were normalised to either *act-1 (dlc-1, egl-1 and ced-13)* or *pmp-2 (lin-35 and ced-9) C*~T~ values. Relative expression levels were calculated by using the Pfaffl method.^[@bib58]^

Mammalian two-hybrid system
---------------------------

Experiments were performed based on the Checkmate Mammalian Two-Hybrid system (Promega, Madison, WI, USA). *C. elegans* KRI-1 (isoform a) and DLC-1 were cloned from whole-worm cDNA using standard cloning techniques (See [Supplementary Table S1](#sup1){ref-type="supplementary-material"} for primers). KRI-1 was inserted into the pACT vector, and DLC-1 was inserted into both the pACT and pBIND vectors. HEK293T cells were seeded in 24-well plates with a density of 1.4 × 10^5^ cells per well. Next day the cells were transfected at 70--90% confluence with 50 ng GFP vector, 150 ng pG5luc, 150 ng pACT (with appropriate insert), 150 ng pBIND (with appropriate insert) and 1 *μ*l lipofectamine 2000 (Life Technologies, Naerum, Denmark) in 50 *μ*l DMEM serum-free medium (Life Technologies) per well. After 24 h, the medium was refreshed. Fourty-eight hours after transfection, the cells were lysed, and 50 *μ*l of lysate were transferred to 96-well plates. GFP fluorescence was measured using a Perlkin Elmer Universal Microplate Analyzer Fusion-Alpha FPHT. Fourty microlitre luciferase (Promega) was added to each well, and fluorescence was measured in an Enspire 2300 Multi label Reader. Background levels from empty cells were subtracted and luciferase/GFP was plotted as binding efficiency. All measurements were run in technical triplicates. Non-transfected cells, cells transfected with either pACT or pBIND without insert or both were used as negative controls.
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![Inactivation of *dlc-1* results in increased germ cell apoptosis independent of the dynein motor complex. (**a**) Mean number of apoptotic cells per gonad arm after RNAi against *dlc-1*, scored with both CED-1::GFP and DIC. (**b**) Epifluorescence ( × 40) and DIC ( × 40) pictures of ctrl and *dlc-1(RNAi)* gonads. Arrows point to apoptotic cells. (**c**) Comparison between apoptosis scored with DIC and CED-1::GFP in *dlc-1(RNAi), ced-6(tm1826)* and *ced-5(tm1950)* animals. (**d)** Mean number of apoptotic cells in the head of freshly hatched L1 larvae in N2, *ced-5(tm1950)* and *ced-6(tm1826)* mutants treated with ctrl of *dlc-1* RNAi, scored with DIC. (**e**) Mean number of apoptotic cells per gonad arm after RNAi against *dlc-1--6*, scored with CED-1::GFP. (**f**) Mean number of apoptotic cells per gonad arm in *dhc-1(RNAi)*-treated animals. All graphs are mean (±S.D.) of at least three independent experiments. *N*=20--40 gonad arms for each experiment. \**P*\<0.05](cddis2013319f1){#fig1}

![*dlc-1(RNAi)* induces apoptosis through CED-3, CED-9 and LIN-35 (**a**). Mean number of apoptotic cells per gonad arm after RNAi against *dlc-1* in a *ced-3(n717)* mutant, scored with CE-1::GFP. (**b**) Mean number of apoptotic cells per gonad arm after RNAi against *dlc-1* in a *ced-9(n1950)* mutant, scored with DIC. (**c**) Mean number of apoptotic cells per gonad arm after RNAi against *dlc-1* in *cep-1(gk138)* mutants, scored with CED-1::GFP. (**d**) Mean number of apoptotic cells per gonad arm after RNAi against *dlc-1* in *pch-2(tm1458)* mutants, scored with CED-1::GFP. (**e**) Mean number of apoptotic cells per gonad arm after RNAi against *dlc-1* in *gla-3(ok2684)* mutants, scored with CED-1::GFP. (**f**) Mean number of apoptotic cells per gonad arm after RNAi against *dlc-1* in *lin-35(n745)* mutants, scored with DIC. All graphs are mean (±S.D.) of at least three independent experiments. *N=*20--40 gonad arms for each experiment. \**P*\<0.05](cddis2013319f2){#fig2}

![DLC-1 is acting upstream of EGL-1 and CED-13 in response to IR. (**a**) Mean number of apoptotic cells per gonad arm after IR in ctrl and *dlc-1* RNAi worms, scored with CED-1::GFP. (**b**) Western blot of CEP-1 localisation in nuclear (nuc) and cytoplasmic (cyto) extractions from worms fed ctrl or *dlc-1* RNAi. First lane is whole-worm extract form *cep-*1 mutants. Actin is used as loading control. (**c**) qPCR of *egl-1* and *ced-13* transcription after IR in worms fed ctrl or *dlc-1* RNAi. Relative expression is calculated by the Pfaffl method and compared with ctrl without IR. (**d**) Mean number of apoptotic cells per gonad arm after RNAi against *dlc-1* in N2, *ced-13(tm536), egl-1(n1084n3082)* and *ced-13(tm536);egl-1(n1084n3082)* mutants, scored with DIC. (**e**) Mean number of apoptotic cells per gonad arm in *sir-2.1(ok434), pmk-3(ok169)* and *pmk-1(km25)* treated with *dlc-1* RNAi, scored with DIC. All graphs are mean (±S.D.) of at least three independent experiments. For the apoptosis assays, *N=*20--40 gonad arms for each experiment. \**P*\<0.05](cddis2013319f3){#fig3}

![Transgenic worm expressing *P*~*dlc-1*~*,dlc-1::gfp*. (**a**) Expression of DLC-1::GFP under control of the *dlc-1* promoter. (**b**) Expression of DLC-1::GFP in body wall muscles. (**c**) DLC-1::GFP is expressed in germ cells and oocytes. (**d**) DLC-1::GFP is expressed in the rectal valve cells. (**e**) DLC-1::GFP expression in unidentified cells in the head. (**f**) Quantification (by ImageJ) of DLC-1::GFP expression after exposure to 0 and 60 Gy. (**g**) Expression of DLC-1::GFP 24 h after exposure to 60 Gy](cddis2013319f4){#fig4}

![DLC-1 is functioning cell nonautonomously through *kri-1*. (**a**) Mean number of apoptotic cells per gonad arm after RNAi against *dlc-1* in N2, *ppw-1(pk2505)* and *rrf-1(pk1417)* mutants, scored with DIC. (**b**) Mean number of apoptotic cells per gonad arm in *P*~*dlc-1*~*,dlc-1::gfp* 24 h after treatment with 120 Gy, scored with CED-1::GFP. (**c**) Mean number of apoptotic cells per gonad arm after RNAi against *dlc-1* in N2 and *kri-1(ok1251)* mutants. All graphs for apoptosis are mean (±S.D.) of at least three independent experiments. For the apoptosis assays, *N*=20--40 gonad arms for each experiment. \**P*\<0.05. (**d**) Expression of KRI-1::GFP after treatment with *dlc-1* RNAi for 3 days. Quantified by ImageJ. Representative of three independent experiments. (**e**) DLC-1--DLC-1 interaction by the use of mammalian two-hybrid system. Representative of three independent experiments (**f**). DLC-1--KRI-1 interaction by use of mammalian two-hybrid system](cddis2013319f5){#fig5}

![Model for the role of DLC-1 in regulation of germ cell apoptosis. Our data demonstrate that DLC-1 acts cell nonautonomously through the *kri-1* pathway in response to IR by indirectly regulating the activity of the proteins EGL-1, CED-13 and LIN-35 to induce germ cell apoptosis](cddis2013319f6){#fig6}
